Piramal Pharma
Poised For Growth
The Piramal Group has interests in a variety of industries, including financial services (Piramal Enterprises), real estate (Piramal Realty) and pharmaceuticals (Piramal Pharma). The Group's revenue is expected to be around USD 1.9 billion in FY 2022 with operations in 30 countries and brand recognition in more than 100 markets.